- Home
- / ConvaTec
ConvaTec
Stock Price
£2.2
2024-10-29
Market Capitalization
£4.6 B
2024-10-29
Revenue
$2.3 B
FY, 2024
ConvaTec Summary
Company Summary
- Overview
- ConvaTec Group is a medical products and technologies company focused on solutions for the management of chronic conditions. It provides products used for chronic and acute wound care, ostomy care, continence and critical care, and infusion care used in the treatment of diabetes and other conditions.
- Type
- Public
- Status
- Active
- Founded
- 1978
- HQ
- Reading, GB | view all locations
- Website
- https://www.convatec.co.in/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Jonny Mason, Chief Financial Officer
David Shepherd, President and Chief Operating Officer, Global Advanced Wound Care
Kjersti Grimsrud, President and Chief Operating Officer, Infusion Care
Operating MetricsView all
Countries
100
H1, 2022
Consumers (Me+ Programme)
300K
FY, 2019
Manufacturing Facilities
9
FY, 2021
LocationsView all
62 locations detected
Reading, England HQ
United Kingdom
3 Forbury Place, Forbury Estate, 23 Forbury Road
Bridgewater, NJ
United States
CenterPointe II 1160 Route 22 East; Suite 201
Greensboro, NC
United States
7815 National Service Rd #600
Oklahoma City, OK
United States
Buenos Aires, CABA
Argentina
Cerrito 1070 Piso 3
Melbourne, Victoria
Australia
Level 2, Building 5, Brandon Business Park, 530 Springvale Road, Brandon Park
ConvaTec Financials
Summary Financials
- Revenue (FY, 2024)
- $2.3B
- Gross profit (FY, 2024)
- $1.5B
- Net income (FY, 2024)
- $190.5M
- Cash (FY, 2024)
- $64.7M
- EBIT (FY, 2024)
- $320.6M
- Enterprise value
- $5.7B